Supervised learning approach a necessary and important step in monitoring drug-related social media posts

Social media, such as Facebook and Twitter, provides many users with an outlet to share opinions online among a broad audience.  Some of these discussions concern their experiences with prescription and over-the-counter (OTC) medications.  These conversations can have an outsized influence on the public perception of the products they discuss.  The sentiment of individual posts regarding the efficacy and side effects of medications can be either positive or negative.  Consumers may also disclose misuse or abuse of the product.  Occasionally,

Read More »

Veracuity joins COVID-19 Evidence Accelerator

In April 2020, the Veracuity team developed a survey tool for the collection of data from hospitalized COVID19 patients. This initiative was implemented and widely distributed by the Alliance for Clinical Research Excellence and Safety (ACRES). At the recommendation of the Principal Deputy Commissioner of Food and Drugs, Amy P. Abernethy, M.D., Ph.D., Veracuity joined the COVID-19 Evidence Accelerator, organized by the Reagan-Udall Foundation for the FDA in collaboration with Friends of Cancer Research. The scarcity of evidence and ambiguity

Read More »

Subscribe to our newsletter